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Background. Intravesical pressure (IAPivp) measurement is considered to be the gold standard for assessment of intra-abdominal
pressure (IAP). This study evaluated a new minimally invasive IAP monitoring device (CiMON) against three other devices in
a wide range of clinically relevant IAP and in diﬀerent body positions in healthy pigs. Methods. The CiMON catheter (IAPCiM)
and another balloon-tipped catheter (IAPspie) were positioned into the stomach. Fluid-ﬁlled catheters were used for direct
intraperitoneal (IAPdir) and IAPivp measurement. Both in supine and 25
◦ head-of-bed positions, IAP was increased from baseline
to 30mmHg. At every IAP level, 4 IAP measurements were recorded simultaneously. Mean diﬀerences and the limits of agreement
were calculated. Results. Bias between IAPCiM and IAPspie was nearly zero with very good agreement, both in supine and 25
◦
position. In supine position, IAPCiM slightly overestimated IAPivp and IAPdir by 1.5 and 2.1mmHg with reasonable agreement.
In 25
◦ position, IAPCiM underestimated IAPivp and IAPdir by 1.0 and 0.5mmHg, again with reasonable agreement. Conclusions.
Agreement between IAPCiM and IAPspie was very good, while good-to-moderate agreement exists between IAPCiM and IAPdir
or IAPivp. Simplicity, continuous monitoring, and the combination with a feeding tube should lead to further clinical studies,
evaluating this new CiMON device.
1.Introduction
Intra-abdominal hypertension (IAH) and abdominal com-
partment syndrome (ACS) have signiﬁcant morbidity and
mortality [1–3]. IAH is deﬁned as a sustained elevated intra-
abdominal pressure (IAP) ≥ 12mmHg without organ dys-
function, and ACS is deﬁned as a sustained IAP > 20mmHg
associated with new organ dysfunction. The deﬁnitions of
IAH and ACS are thus based on the determination of intra-
abdominal pressure (IAP), measured at end-expiration in
the complete supine position after ensuring that abdominal
muscle contractions are absent [4]. Although IAP measured
intermittently via the bladder (with an instillation volume
of maximal 25mL sterile saline) is the current standard
of care to screen patients for IAH/ACS, this technique
has important limitations. Several contraindications for
bladder catheterization exist (e.g., pelvic trauma and urinary
tract infection). Moreover, bladder measurements are still
mostly intermittent in nature, being labour intensive and
possibly preventing timely recognition of signiﬁcant changes
in IAP [5]. Some fully automated continuous monitoring
techniques have been described and validated in vitro and
in animal laboratories [6–8]. Several of these more invasive
techniques perform very well in laboratory settings but are
less feasible in clinical scenarios. Transgastric devices might
beareasonableminimallyinvasivealternativeforcontinuous
IAP monitoring [9–13]. Recently, a new transgastric device
became available that uses an air-ﬁlled balloon positioned
on a nasogastric feeding tube [14]. The aim of the present
study was to evaluate this new device against three other
IAP measurement devices (direct intraperitoneal, bladder,
and gastric) in a wide range of clinically relevant IAP and
in diﬀerent body positions with regard to precision and
applicability in a future human investigation.2 Critical Care Research and Practice
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Figure 1: (a) Pig setup in head of bed (HOB) 25◦ in animal lab at Leuven University. (b) CiMON monitor and probe with feeding lumen.
2.MaterialsandMethods
2.1. Animal Instrumentation. This study was performed in
accordance with the national guidelines for ethical animal
research and was approved by the local Institutional Ethics
Committee on Animal Care and Use. After overnight fasting,
6 anaesthetized and paralyzed pigs (mean body weight of
39 ± 1kg) were mechanically ventilated (Evita XL, Drager,
Lubeck, Germany) using an oxygen concentration (FiO2)
of 35%, a tidal volume (TV) of 9mL/kg with an inspira-
tion/expiration ratio of 1/2 and a PEEP of 7cmH20. Respi-
ratory rate was adjusted to maintain arterial paCO2 between
35–45mmHg. These settings were kept constant throughout
the experiment. A femoral artery catheter was inserted
for blood pressure monitoring and blood gas sampling.
Ringer lactate at 4mL·kg−1·h−1 (Viaﬂex, Baxter, Lessines,
Belgium) and HAES-steril at 5mL·kg−1·h−1 (FreeFlex, Fre-
senius,Friedberg,Germany)wereadministeredviaafemoral
vein catheter. The pigs were instrumented with 4 diﬀerent
IAP measurement catheters. Two balloon-tipped catheters
(IAPspie and IAPCiM) were positioned transesophageally into
the stomach. Their position was checked afterwards by
radioscopy. A small midline laparatomy was performed and
a ﬂuid-ﬁlled catheter (IAPdir) was placed intra-peritoneally,
caudally to the stomach. A standard Foley catheter (IAPivp)
was inserted into the bladder. All catheters were exteriorised,
and the laparotomy was carefully closed water-sealed in two
layers. Figure 1(a) shows the pig setup.
2.2. Measurements of IAP. Measurements of IAP were based
on 4 diﬀerent measurement principles.
Spiegelberg Balloon-Tipped Catheter IAP Measurement
(IAPspie). This IAP measurement device (Spiegelberg, Ham-
burg, Germany) has been described previously and consists
of a nasogastric tube-like catheter (outer diameter 3mm)
equipped with an air-ﬁlled balloon (total ﬁlling volume
1mL) connected to a device for automatic zeroing, control,
and pressure measurement [7, 15].
CiMON Balloon-Tipped Catheter IAP Measurement
(IAPCiM). The CiMON system (Pulsion Medical Systems,
Munich, Germany) consists of a nasogastric probe (outer
diameter 5.3mm) with a small air-inﬂatable balloon (total
ﬁlling volume 1.1mL) located at the distal tip of the probe
(Figure 1(b)). The probe has one lumen that connects the
air-ﬁlled balloon with the IAP monitor and one feeding
lumen that can also be used for guide wire introduction.
The balloon is connected to a device for automatic zeroing,
control, and pressure measurement.
Intravesical Pressure IAP Measurement (IAPivp). Before each
measurement, the bladder was emptied. An instillation
volume of 20mL saline was injected to measure in-
travesical pressure [4]. Twenty milliliter is in accordance
with the research recommendations of the World Soci-
ety on Abdominal Compartment Syndrome (WSACS,
http://www.wsacs.org/), and it was well below the average
volume of ﬂuid needed to increase the intravesical pressure
by 2mmHg in pigs with an IAP of 20mmHg [16, 17].
The 10 Ch multiple-hole ﬂuid-ﬁlled catheter (Cystoﬁx,
BBraun, Melsungen, Germany) was connected to a pressure
transducer.Thelevelofthesymphysispubiswastakenaszero
reference,bothwiththepigsupineandin25◦ headelevation.
Direct Intra-Peritoneal IAP Measurement (IAPdir). The mul-
tiple-hole ﬂuid-ﬁlled catheter was connected to a two-way
stopcock. One side was continuously ﬂushed (5mL/h) to
prevent obstructions in the catheter lumen. The other side
was connected to a pressure transducer and the symphysis
pubis was taken as zero reference, both with the pig supine
and in 25◦ head elevation.
2.3. Experimental Protocol. The pig being in supine position,
IAP was increased from baseline up to 20 and 30mmHg (as
measured by the intravesical IAP) by infusing warmed saline
intraperitoneally. At each IAP-level, 2 times 4 continuous
IAP-traces (2 quadruplets) were recorded simultaneously
for 5 minutes (after a stabilization period of 5 minutes).Critical Care Research and Practice 3
Table 1: Statistics of comparison between diﬀerent device readings in the supine position.
Device Bias (mmHg) Precision (mmHg) Limits of agreement (mmHg) Percentage error
IAPCiM−IAPspie 0.2 0.9 −1.6t o2 .09 . 6
IAPCiM−IAPdir 2.1 2.5 −2.9t o7 .1 31.6
IAPCiM−IAPivp 1.5 2.5 −3.5t o6 .6 24.9
Mean diﬀerence between diﬀerent device readings (bias), precision (standard deviation), percentage error (%), and limits of agreement in the supine position.
CiMON balloon-tipped catheter pressure (IAPCiM), Spiegelberg balloon-tipped catheter pressure (IAPspie), direct intraperitoneal pressure (IAPdir), and
intravesical pressure (IAPivp)m e a s u r e m e n t .
Then, IAP was decreased again to 20mmHg and baseline,
and measurements were repeated. Then, the pig was placed
in 25◦ head of bed position. Similarly, IAP was increased
from baseline up to 30mmHg and back to baseline and
IAP-traces were recorded. In each position, a horizontally
calibrated radioscopy was performed to measure vertical
height diﬀerences between the diﬀerent catheter tips. At the
end of the experiment, animals were sacriﬁced by hypertonic
potassium chloride injection under deep anaesthesia.
2.4. Data Acquisition and Data Analysis. IAPdir and IAPivp
were captured by a multimodal monitor (Philips IntelliVue,
Best, The Netherlands) connected to a computer for real-
time data saving via a LAN. The Spiegelberg device (IAPspie)
was connected via a serial port (50Hz) to another computer
for real-time data saving. The CiMON device (IAPCiM)w a s
connected to a third computer via a serial port (50Hz).
The internal clocks of the 3 diﬀerent computers were
synchronized before starting data acquisition. Afterwards,
time-synchronized IAP data from diﬀerent devices were
analyzed oﬀ line with dedicated software (Matlab 6.5.1,
MathWorks, USA, and Trendface Solo 1.1.5, Ixellence,
Hamburg, Germany). Since IAPdir was always zeroed at
the level of the symphysis pubis, IAPdir was corrected for
the height of the ﬂuid column between the intraperitoneal
measurement point and the pressure transducer. From every
IAP quadruplet, we calculated 3 diﬀerent IAP data pairs
(IAPCiM−IAPspie,a n dI A P CiM−IAPivp,I A P CiM−IAPdir)a n d
corrected them for the vertical height diﬀerence between
the catheter tips, as measured with horizontally calibrated
radioscopy. All IAP values were measured end-expiratory
a n da r ee x p r e s s e di nm m H g .
2.5. Statistical Analysis. Results are expressed as mean ±
standard deviation (SD = precision). According to the
method of Bland Altman, bias was calculated as the mean
diﬀerence between values obtained with diﬀerent measure-
ment techniques, and limits of agreement were calculated
as mean ± 2SD [17]. Percentage error was calculated as the
limits of agreement divided by the mean IAP. Based on the
recent WSACS recommendations, good agreement between
2 techniques was deﬁned as follows: bias ≤ 1mmHg,
limits of agreement between −4 to 4mmHg, and a maximal
percentage error of 25% [18].
3. Results
The CiMON probe was successfully inserted transesophag-
eally in all pigs. A total of 528 IAP measurements (248 in
supine and 280 in 25◦ head-up elevation position) were used
to calculate agreement between the diﬀerent devices, result-
ing in 62 IAP quadruplets in supine and 70 IAP quadruplets
in 25◦ head-up elevation position. In supine position, 10
quadruplets (40 IAP measurements), and in 25◦ position,
2 quadruplets (8 IAP measurements) dropped out due to
technical reasons. Baseline IAP, measured intraperitoneally,
was 3.9 ± 1.9mmHg. IAP ranged from 2.6 to 31.2mmHg
(average 15.2mmHg) in supine position and from 7.0 to
40.4mmHg (average 22.1mmHg) in 25◦ position. In the
supine position, the CiMON and the bladder catheter were
almost on the same height (diﬀerence 0.7cm), while at 25◦
head elevation, the CiMON probe was 7.5cm higher than
the bladder catheter. Bias between IAPCiM and IAPspie was
nearly zero with very good agreement. IAPCiM overestimated
IAPivp and IAPdir by 1.5 and 2.1mmHg, respectively with
reasonable agreement. Data on precision, percentage error
and limits of agreement between diﬀerent techniques in
supine position are presented in Table 1 and Figure 2.I n
25◦ head-up elevation, there was also very good agreement
between the intragastric IAP measurements (CiMON and
Spiegelberg). IAPCiM underestimated IAPivp and IAPdir by
1.0 and 0.5mmHg, respectively, again with reasonable agree-
ment. Mean diﬀerences between diﬀerent device readings,
precision, percentage error, and limits of agreement in the
25◦ head-up elevation position are presented in Table 2 and
Figure 3.
4. Discussion
This study evaluated a new intragastric IAP measurement
device (CiMON) against three other IAP measurement
devices (gastric, direct, and bladder) in a wide range of
clinically relevant IAP and in diﬀerent body positions.
First of all, we validated the new CiMON device against
another balloon-tipped intragastric IAP measurement tech-
nique (Spiegelberg). This device has already been evaluated
as a valid tool for IAP measurement [9, 10]. As expected, we
found very good agreement between these two intragastric
techniques, both in supine and in 25◦ head-up elevation
positions. Although calibration-triggered volume expansion
of one balloon was captured by the other balloon, signiﬁcant
interference between both IAP measurements was negligible.
Second, reasonable agreement was found between CiMON4 Critical Care Research and Practice
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Figure 2: Bland Altman plots for comparing diﬀerent methods measuring intra-abdominal pressure (IAP) in supine position. Horizontal
full line: bias; horizontal dashed line: upper and lower limits of agreement. (a) CiMON balloon-tipped catheter IAP measurement (IAPCiM)
versus Spiegelberg balloon-tipped catheter IAP measurement (IAPspie). (b) IAPCiM versus direct intraperitoneal IAP measurement (IAPdir).
(c) IAPCiM versus intravesical pressure IAP measurement (IAPivp).
Table 2: Statistics of comparison between diﬀerent device readings in the 25◦ head-up elevation position.
Device Bias (mmHg) Precision (mmHg) Limits of agreement (mmHg) Percentage error
IAPCiM−IAPspie −1.1 1.1 −3.2t o1 .0 11.0
IAPCiM−IAPdir −0.5 2.7 −5.8t o4 .8 26.3
IAPCiM−IAPivp −1.0 2.2 −5.4t o3 .3 19.9
Mean diﬀerence between diﬀerent device readings (bias), precision (standard deviation), percentage error (%), and limits of agreement in the 25◦ head-up
elevation position. CiMON balloon-tipped catheter pressure (IAPCiM), Spiegelberg balloon-tipped catheter pressure (IAPspie), direct intraperitoneal pressure
(IAPdir), and intravesical pressure (IAPivp)m e a s u r e m e n t .
and intravesical IAP measurements. Bias was not more
than 1.5mmHg with a percentage error less than 25% in
both supine and 25◦ anti-Trendelenburg position, and limits
of agreement were not above 6mmHg. Similar agreement
was obtained when CiMON data was evaluated against
directly measured IAP. Our results are comparable with data
from others, evaluating several intragastric devices for IAP
measurement [11–13]. Comparing gastric with intravesical
IAP in patients undergoing laparoscopic cholecystectomy,
Sugrue et al. found limits of agreement of −4 to +3mmHg
with a bias of 0.35mmHg (IAP range from 8 to 20mmHg)
[11]. Turnbull et al. compared gastric with directly measured
IAP in 29 patients undergoing elective laparoscopy, both in
supine an 15◦ head-down position [13]. Bias was nearly zero,
and limits of agreement were −2.5 to 4.5mmHg in supine
and −4.6 to 2.4mmHg in Trendelenburg position. De Waele
et al. found that IAP measured using an intragastric com-
pliance catheter reliably reﬂects the reference IAP in seven
patients undergoing laparoscopic cholecystectomy [19]. In
these studies, the air-ﬁlled experimental setup allowed the
a u t h o r st on e g l e c th e i g h td i ﬀerences. In our study, we used
intra-abdominal ﬂuid to generate IAP, better mimicking the
clinical situation. Indeed, in critically ill patients, IAH and
ACS are often induced by ﬂuid accumulation such as ascites,
generalized edema, paralytic ileus, or hemoperitoneum.
Therefore, we measured hydrostatic height diﬀerences and
corrected for them. However, measuring hydrostatic height
diﬀerences in clinical practice is time consuming and not
straightforward. This again stresses the need for standardisa-
tion of IAP measurements in the supine position, as statedCritical Care Research and Practice 5
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Figure 3: Bland Altman plots for comparing diﬀerent methods measuring intra-abdominal pressure (IAP) in 25◦ head-of-bed position.
Horizontal full line: bias; horizontal dashed line: upper and lower limits of agreement. (a) CiMON balloon-tipped catheter IAP measurement
(IAPCiM) versus Spiegelberg balloon-tipped catheter IAP measurement (IAPspie). (b) IAPCiM versus direct intraperitoneal IAP measurement
(IAPdir). (c) IAPCiM versus intravesical pressure IAP measurement (IAPivp).
by the consensus deﬁnitions of the WSACS, making the
comparisoninthesupinepositionthemostimportantinthis
study [4, 17].
This new CiMON device has several advantages but
some questions remained unanswered. The risk for infection
is negligible, nearly all ICU patients need a nasogastric
feeding tube in place, and probe position is often checked
by radioscopy. CiMON measurement and zeroing is fully
automated, saving time and labour intensive actions. The
CiMON device monitors continuous IAP, allowing IAP
and IAP-derived data trends such as abdominal perfusion
pressure (= mean arterial pressure − IAP) to be used to
treat critically ill patients [20–23]. However, the eﬀects
of gastric migratory motor complexes, enteral feeding, or
administration of prokinetics on IAP measurements are not
known [24]. Piessevaux et al. found erythromycine to result
in fundic pressure wave changes of 20mmHg in conscious
healthy volunteers [25]. Yet, these temporary perturbations
might become irrelevant when continuous IAP monitoring
is done. Further studies are necessary to answer these
questions.
In conclusion, this study evaluated a new transgastric
IAP measurement device (CiMON) against three other IAP
measurement devices (direct, bladder, and gastric) in a wide
range of clinically relevant IAP and in diﬀerent body posi-
tions. Agreement between both intragastric balloon-tipped
devices was very good, while agreement between CiMON
and direct or intravesical IAP measurement was reasonable.
The advantages of simplicity, continuous monitoring possi-
bilities and the combination with a feeding tube should lead
to further clinical studies, evaluating this new device.
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